| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 967,198 | 840,502 | 768,356 | 894,073 | | Cost of Revenue | 243,197 | 687,799 | 634,652 | 754,330 | | | Gross Profit | 724,001 | 152,703 | 133,704 | 139,743 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 678,496 | 116,992 | 102,130 | 111,613 | | Non Recurring |
-
|
-
| 1,231 | 112,808 | | Others | 14,089 | 13,303 | 12,491 | 13,153 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 31,416 | 22,408 | 17,852 | (97,831) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,108 | 1,437 | 2,521 | 2,261 | | Earnings Before Interest And Taxes | 34,524 | 23,845 | 20,373 | (95,570) | | Interest Expense | 6,520 | 4,531 | 6,176 | 7,058 | | Income Before Tax | 28,004 | 19,314 | 14,197 | (102,628) | | Income Tax Expense | 7,537 | 5,907 | 4,317 | (12,180) | | Minority Interest | (2,500) | (1,652) | (35) | 642 | | | | Net Income From Continuing Ops | 22,154 | 11,755 | 9,845 | (89,806) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 17,967 | 11,755 | 9,845 | (89,806) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $17,967 | $11,755 | $9,845 | ($89,806) |
|
0.05% Nasdaq 
0.08 (0.56%) 
Income Statement
